Left Main Bifurcation Live Case Series
Published: 19 February 2021
-
Views:
2618
-
Likes:
3
Overview
Full programme
-
Views:
2618
-
Likes:
3
Overview
In this live case series Professor James Spratt and Dr Thierry Lefèvre will guide us through a progressive and comprehensive educational journey around the globe. We will join various live case centres, over 11 months to learn from over 30 expert perspectives on how LMPCI is performed in a contemporary setting.
The aim of the series being, to break down the complexity of the whole procedure into a systematic, algorithmic, step by step approach. Simplified for us by top operators and faculty, through live cases and relevant flash lectures to support the learning.
With LM PCI being the most divisive procedure performed in interventional cardiology currently, the need to stay informed and aware of innovation in products and techniques has become all the more important.
For more information on the Left Main Bifurcation series, and to watch events LIVE, please register by clicking HERE
Now more than ever, Boston Scientific is committed to finding new and innovative ways to support you as you look to provide the very best patient care.
WITH YOU every day, educating, innovating and tackling Left Main Bifurcation together.

Series overview
Part 1
The Process Behind the Procedure: An Introduction to Left Main PCI
Part 2
The Role of IVUS
Part 3
Approach to LMS & Choosing Stent Strategy
Part 4
Lesion Preparation
Part 5
Provisional LM Stenting (Single Stent)
Faculty Biographies

James Spratt
Professor of Interventional Cardiology
James Spratt is a Professor of Interventional cardiology. A high-volume Interventional Cardiologist with an international reputation in complex PCI, with a sub-speciality interest in intravascular imaging and CTO. Widely published within this area and has performed live case demonstrations globally. He is interested in medical education and is the Founder of Optima Education.
Dr Spratt is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

Thierry Lefèvre
Head of the Interventional Cardiology
Dr Thierry Lefèvre is Head of the Interventional Cardiology Department and Head of Research at the Institut Cardiovasculaire Paris Sud at Institut Hospitalier Jacques Cartier in Massy, France. He was previously a part-time hospital practitioner in the Cardiology Department at the Hôpital de Pontoise, France, where he was in charge of the intensive care unit (ICU), echocardiography and interventional cardiology. He is a Fellow of the European Society of Cardiology (ESC) and a Fellow of the Society for Angiography and Interventions. Dr Lefèvre earned his degree in medicine from the University of Paris V in 1985.

Joost Daemen
Interventional cardiologist
Dr Joost Daemen, MD, PhD obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of 4 trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

José M de la Torre Hernández
Head of Hemodynamics and Interventional Cardiology
Professor Jose M de la Torre is an interventional cardiologist and Head of the Hemodynamics and Interventional Department of the Marques de Valdecilla University of Santander, Spain.
He is member of the scientific committee of the Spanish Society of Cardiology and is fellow of the European Society of Cardiology. Former associate director of the Trans Catheter Therapeutics Meeting in US. Faculty of ESC, PCR, ACC and TCT meetings. Coordinator of the ESTROFA, XIMA and LITRO study groups. Prof De La Torre is a member of the editorial committee of the Revista Español de Cardiologia,, Consultant editor of JACC Cardiovascular interventions, Section editor in Eurointervention and Editor in chief of REC: Interventional Cardiology. Research coordinator in EPIC foundation.
In 2016-2017 he was a visiting scientist at Harvard-MIT biomedical engineering center. His research interests include intravascular imaging, interventions on coronary artery…

Robert A Byrne
Director of Cardiology
Professor Robert Byrne is Director of Cardiology at the Mater Private Hospital, Dublin, and Chair of Cardiovascular Research at the Royal College of Surgeons.
He is also head of the Cardiovascular Research Institut(CVRI Dublin) which is a collaboration with the Royal College of Surgeons in Ireland (RCSI). Its research focus is on Outcomes Research, Clinical Trials, Core Laboratory and Systematic Reviews.
Professor Byrne’s internship and general medical training was in the Mater Hospital, Dublin and Mayo Clinic, Arizona. His Cardiology fellowship was in Ireland and at the German Heart Centre, Munich, Germany.
Since then he has held several strategic positions at German Heart Centre, including Consultant Cardiologist and Deputy Director of Cardiology. He returns to Ireland to the role of Director of Cardiology at Mater Private Hospital and RCSI Chair of Cardiovascular Research.
Professor Byrne’s specialty interests…

Barbara Stähli
Interventional Cardiologist
Prof Stähli is the Deputy Head of the cardiac catheterization laboratory at the Clinic for Cardiology, University Hospital Zurich.

Olivier Darremont
Interventional Cardiologist
Olivier Darremont has been an Interventional cardiologist at the Clinique Saint-Augustin in Bordeaux since 2000
He is also a Board Member and co-Founder of The European Bifurcation Club.

Margaret B McEntegart
Consultant in Interventional Cardiology
Dr McEntegart is a Consultant Interventional Cardiologist at Golden Jubilee National Hospital and Honorary Associate Clinical Professor of the University of Glasgow, and clinical lead for the complex PCI and CTO programmes.